Publication: Rivaroxaban versus fondaparinux for thromboprophylaxis after endovenous laser ablation
Rivaroxaban versus fondaparinux for thromboprophylaxis after endovenous laser ablation
Date
Date
Date
Citations
Keo, H. H., Baumann, F., Diehm, N., Regli, C., & Staub, D. (2017). Rivaroxaban versus fondaparinux for thromboprophylaxis after endovenous laser ablation. Journal of Vascular Surgery : Venous and Lymphatic Disorders, 5(6), 817–823. https://doi.org/10.1016/j.jvsv.2017.04.017
Abstract
Abstract
Abstract
OBJECTIVE Endovenous heat-induced thrombosis (EHIT) and deep venous thrombosis (DVT) are well-known complications after superficial endovenous thermoablation. We investigated the efficacy of rivaroxaban in preventing EHIT and DVT after endovenous laser ablation (EVLA). METHODS We retrospectively analyzed a consecutive series of patients presenting with truncal varicosis class C to C undergoing EVLA. After EVLA, all patients received oral rivaroxaban (10 mg) or subcutaneous fondaparinux (2.5 mg) once daily for 3 consecutive days. Th
Additional indexing
Creators (Authors)
- Keo, Hong H
- Baumann, Frederic
- Diehm, Nicolas
- Regli, Christian
- Staub, Daniel
Journal/Series Title
Journal/Series Title
Journal/Series Title
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Citations
Keo, H. H., Baumann, F., Diehm, N., Regli, C., & Staub, D. (2017). Rivaroxaban versus fondaparinux for thromboprophylaxis after endovenous laser ablation. Journal of Vascular Surgery : Venous and Lymphatic Disorders, 5(6), 817–823. https://doi.org/10.1016/j.jvsv.2017.04.017
